MetLife Investment Management, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1529735
Whippany, NJ
Position in REGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$18,208,806
-$450,379 QoQ
Shares Held
23,567
-2.5% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,503,407 across 207 Biotechnology names. REGN ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.DE
|
708,527 | $13,858,788 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,208,806 | 23,567 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $18,659,185 | 24,174 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $14,235,551 | 25,318 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,896,750 | 26,470 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $17,566,268 | 27,697 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $20,116,199 | 28,240 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $29,400,029 | 27,967 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $30,138,285 | 28,675 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $24,030,487 | 24,967 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $23,016,467 | 26,206 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $21,919,539 | 26,635 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $19,828,829 | 27,596 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $23,229,432 | 28,271 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,563,186 | 28,501 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $19,984,118 | 29,010 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $17,516,955 | 29,633 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $20,559,389 | 29,437 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $14,751,675 | 23,359 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $15,445,403 | 25,522 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $13,557,441 | 24,273 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $11,871,082 | 25,090 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $12,302,879 | 25,466 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $14,838,088 | 26,507 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $16,452,510 | 26,381 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $10,054,379 | 20,591 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||